What you need to know about new Wegovy trial results, the latest long COVID symptom, and more.

Maternity care deserts in the US, mapped (Monday, August 14)

In the United States, over 5.6 million pregnant people live in areas with little to no access to maternity care services, according to new research from March of Dimes. Advisory Board's Gabriela Marmolejos and Lilli Silverston recommend three things stakeholders can do to reduce maternity care deserts and improve pregnancy outcomes.

When you should get your COVID-19 booster, according to experts (Tuesday, August 15)

COVID-19 cases and hospitalizations have been rising over the last few weeks. But with a new COVID-19 booster targeting recent variants coming this fall, should you wait for an updated booster or protect yourself now? Fran Kritz investigates for NPR's "Goats and Soda."

New Wegovy trial results are out. Here's our take. (Wednesday, August 16)

Findings from a new large-scale clinical trial of Novo Nordisk's weight-loss drug Wegovy suggest that it may reduce the risk of serious cardiovascular events by 20%. Advisory Board's Regina Lohr and Gabriela Marmolejos share their three biggest takeaways from the trial and explain how these findings could impact chronic disease prevention.

The latest long COVID symptom: Blue legs? (Thursday, August 17)

Long COVID is already associated with a variety of symptoms, from brain fog to fatigue to chest pain, and a new case report published in The Lancet may have just added a new symptom to the list: blue legs.

Getting more than one shot? Go for the same arm. (Friday, August 18)

When receiving multiple doses of a vaccine, does it matter if you get all your shots in the same arm? A recent study from researchers at Saarland University in Germany published in eBioMedicine sheds light.